Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimentalStaphylococcus aureusendophthalmitis

Intravenous treatment of experimentalSta

Intravenous treatment of experimentalStaphylococcus aureusendophthalmitis: imipenem versus the combination of ceftazidime and amikacin

✍ Michael Engelbert; Herminia Miño de Kaspar; Martina Mette; Martin Thiel; Christo 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 423 KB

A comparison of the quality of life in p

A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin

✍ Dr. Russell D. Cohen; Amy L. Brodsky; Stephen B. Hanauer 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 802 KB

Randomized study of subcutaneous low mol

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies

✍ Giovanni Triolo; Angelo Ferrante; Francesco Ciccia; Antonina Accardo-Palumbo; An 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

## Abstract ## Objective To compare the 2 most efficacious therapeutic regimens, intravenous immunoglobulin (IVIG) and anticoagulation with low molecular weight (LMW) heparin plus low‐dose aspirin, in women with recurrent pregnancy loss associated with antiphospholipid antibodies (aPL). ## Method

Efficacy and efficiency of oral microemu

Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: An open-label retrospective trial

✍ Dr. Giovanni C. Actis; Giuseppe Aimo; Gabriella Priolo; Donatella Moscato; Mario 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

A six-month randomized, controlled, doub

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug–refractory ankylosing spondylitis

✍ Walter P. Maksymowych; Gian S. Jhangri; Avril A. Fitzgerald; Sharon LeClercq; Pe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

## Abstract ## Objective To determine the safety and efficacy of intravenous (IV) pamidronate treatment in ankylosing spondylitis (AS) patients who have had a suboptimal response to nonsteroidal antiinflammatory drugs (NSAIDs). ## Methods Pamidronate at 60 mg was compared with pamidronate at 10

A six-month randomized, controlled, doub

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug–refractory ankylosing spondylitis: Comment on the article by Maksymowych et al

✍ Ranju Singh; Yamini Menon; Raquel Cuchacovich; Luis R. Espinoza 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 2 views